What Makes Align Technology (ALGN) a Solid Choice Right Now?
Zacks Investment Research | Jul 09, 2021 08:13AM ET
Align (NASDAQ:ALGN) Technology, Inc. industry and 38.7% rise of the S&P 500 composite.
The renowned global medical device company has a market capitalization of $48.81 billion. Its first-quarter 2021 earnings surpassed the Zacks Consensus Estimate by 25.13%.
Over the past five years, the company registered earnings growth of 60.1%, way ahead of the industry’s 10.6% rise and the S&P 500’s 2.8% increase. The long-term expected growth rate of 23.2% also exceeds the industry’s growth projection of 13.1%.
Let’s delve deeper.
h3 Key Drivers/h3Invisalign Portfolio Expansion: Investors are optimistic about the advancements rolled out by the company for the Invisalign portfolio. Invisalign adoption among adults rose 5.8% sequentially and 68.5% year over year in the last-reported first quarter. Recently, the company announced the commercial and global availability of the Invisalign G8 with SmartForce Aligner Activation and ClinCheck Pro 6.0, respectively. The company also released My Invisalign app and Virtual Care in various countries. Other notable offerings include the Steraligner aligner cleaning system, Invisalign Stickables and limited-edition Charli D’Amelio x Invisalign Aligner Case.
iTero in Focus: Investors are looking forward to the expanding work flow options of its leading iTero scanners. Few notable developments in the iTero family include extended relation with DECA Dental Group following a new multi-year agreement for the Invisalign system, launch of the iTero Element Plus Series of next generation of intraoral scanners and imaging systems, and others. Align Technology continued to benefit from exocad CAD/CAM products and services revenues during the first quarter.
Image Source: Zacks Investment Research
Strong Solvency Position: Align Technology exited the first quarter of 2021 with cash and cash equivalents of $1.13 billion and no reported debt on its balance sheet, implying strong cash balance.
Upbeat 2021 Guidance: During its last earnings call, the company raised its financial outlook for 2021. The company expects revenues for the year within the range of $3.7-$3.9 billion, indicating a surge of 50-58% from 2020.
h3 Downsides/h3Tough Competition: Align Technology faces significant competition from traditional orthodontic appliance (or wires and brackets) players such as 3M’s Unitek, Danaher (NYSE:DHR) Corporation’s Sybron Dental Specialties and Dentsply International. Stiff competition from products similar to Invisalign Technology persists.
Economic Uncertainty: The current macroeconomic environment across the globe has affected Align Technology’s business fundamentals. The company’s waning earnings is attributable the macro economic crisis that affected the overall dental market. Further, the recent coronavirus outbreak has led to an unstable economic condition for the company.
h3 Estimate Trend/h3Align Technology has been witnessing a positive estimate revision trend for 2021. Over the past 90 days, the Zacks Consensus Estimate for its earnings has moved 14.2% to $10.53.
The Zacks Consensus Estimate for its second-quarter 2021 revenues (slated to be reported on Jul 27) is pegged at $937.52 million, suggesting a 166.1% surge from the year-ago reported number.
h3 Zacks Rank and Other Key Picks/h3A few other top-ranked stocks from the Medical-Dental Supplies industry include Henry Schein (NASDAQ:HSIC), Inc. Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.